Lung Carcinoid
Showing 1 - 25 of >10,000
Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,
Recruiting
- Advanced Lung Carcinoid Tumor
- +11 more
- Everolimus
- Lutetium Lu 177 Dotatate
-
Boston, Massachusetts
- +1 more
Jul 19, 2022
Lung Carcinoid Tumor, Lung Non-Small Cell Carcinoma, Metastatic Lung Carcinoma Trial in Houston (Cone-Beam Computed Tomography,
Completed
- Lung Carcinoid Tumor
- +5 more
- Cone-Beam Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 14, 2022
Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,
Not yet recruiting
- Carcinoid Tumor Lung
- +2 more
- 212-Lead Pentixather
- 203-Lead Pentixather SPECT/CT
-
Iowa City, IowaThe University of Iowa Theranostics Center
Sep 23, 2022
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester
Not yet recruiting
- Neuroendocrine Tumors
- +8 more
-
Iowa City, Iowa
- +1 more
Nov 23, 2022
Caregiver, Lobectomy Patient, Lung Carcinoid Tumor Trial (E-mail, Exercise Intervention, Quality-of-Life Assessment)
Withdrawn
- Caregiver
- +3 more
- +5 more
- (no location specified)
Aug 10, 2021
Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +18 more
- Clinical Encounter
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jul 24, 2023
Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Tumor, Lung Non-Small Cell Squamous Carcinoma Trial in Conroe, Houston
Recruiting
- Lung Atypical Carcinoid Tumor
- +13 more
- Nivolumab
- Stereotactic Body Radiation Therapy
-
Conroe, Texas
- +2 more
Feb 25, 2022
DOTATOC PET/CT for Imaging NET Patients
Recruiting
- Neuroendocrine Tumors
- +15 more
- 68Ga-DOTATOC PET/CT
- 18F-FDG PET/CT
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 2, 2022
Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma Trial (drug, procedure, radiation, other)
Not yet recruiting
- Metastatic Cancer
- +7 more
- Standard of Care Chemotherapy
- +7 more
- (no location specified)
Apr 1, 2022
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,
Completed
- Advanced Solid Tumors
- +8 more
- Modified FOLFOX6
- +3 more
-
Duarte, California
- +11 more
Feb 3, 2021
Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in
Completed
- Gastrin-Producing Neuroendocrine Tumor
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 25, 2020
Carcinoid Tumor Trial in Boston (Ziv-aflibercept)
Active, not recruiting
- Carcinoid Tumor
-
Boston, Massachusetts
- +2 more
Oct 14, 2022
Atypical Carcinoid Tumor, Carcinoid Tumor, Functioning Pancreatic Neuroendocrine Tumor Trial in United States (Cabozantinib
Recruiting
- Atypical Carcinoid Tumor
- +18 more
- Cabozantinib S-malate
- +3 more
-
Anchorage, Alaska
- +425 more
Aug 12, 2022
NSCLC, Small Cell Lung Cancer, Carcinoid Trial in Houston (Proton Therapy)
Terminated
- Non-small Cell Lung Cancer
- +4 more
- Proton Therapy
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 30, 2019
Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer Trial in San Francisco, Vallejo (bevacizumab, 5-fluorouracil,
Terminated
- Gastrointestinal Carcinoid Tumor
- +4 more
- bevacizumab
- +3 more
-
San Francisco, California
- +1 more
Dec 12, 2019
Carcinoid Tumor of the Small Bowel, Neuroendocrine Tumour Trial in Worldwide (Octreotide LAR, 177Lu-DOTA0-Tyr3-Octreotate)
Completed
- Carcinoid Tumor of the Small Bowel
- Neuroendocrine Tumour
- Octreotide LAR
- 177Lu-DOTA0-Tyr3-Octreotate
-
Los Angeles, California
- +38 more
Mar 10, 2022
Respiratory Tract Dysplasia or Lung Cancer, Head and Neck
Recruiting
- Esophageal Cancer
- +3 more
- immunohistochemistry staining method
- +3 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center at UC Health Sciences Cente
Nov 1, 2022
Neuroendocrine Tumors - Patient Reported Outcomes
Enrolling by invitation
- Neuroendocrine Tumors
- +3 more
-
Gainesville, Florida
- +13 more
Jul 7, 2022
Locally Advanced Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Houston (Placebo Administration, Questionnaire
Recruiting
- Locally Advanced Neuroendocrine Neoplasm
- Metastatic Neuroendocrine Neoplasm
- Placebo Administration
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2023
Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors Trial in Worldwide (Everolimus, Placebo, Best
Completed
- Advanced NET of GI Origin
- +2 more
- Everolimus
- +2 more
-
La Jolla, California
- +96 more
Jul 13, 2021
Thoracic Tumors Trial in Spain
Recruiting
- Thoracic Tumors
-
Ferrol, A Coruña, Spain
- +69 more
Nov 9, 2021